Dr. Fudin graduated from Albany College of Pharmacy & Health Sciences (ACPHS) with his Bachelors Degree and his Pharm.D. He was awarded and completed an American Cancer Society Sponsored Fellowship in Oncology / Hematology at SUNY/Upstate Medical Center shortly after his undergraduate work.

He is a Diplomate to the American Academy of Pain Management, a Fellow of the American College of Clinical Pharmacy, and a member of several other professional organizations.  Dr. Fudin is a Section Editor for Pain Medicine, the official journal of the American Academy of Pain Medicine and on the Editorial Board for Practical Pain Management.  He is Founder/Chairman of Professionals for Rational Opioid Monitoring & Pharmacotherapy (PROMPT), an advocacy group in favor of safe opioid prescribing by encouraging clinician education, proactive risk stratification, and appropriate therapeutic monitoring.

Dr. Fudin was a peer reviewer established American Pain Society Clinical Practice Guidelines for Arthritis, for Fibromyalgia, and for Cancer Pain and Palliative Care. He was a panel member for establishing guidelines on the “Use of Chronic Opioids for Chronic Non-Cancer Pain”, a collaborative effort between the American Pain Society and the American Academy of Pain Medicine; these guidelines have been widely disseminated by the American Journal of Pain for use by healthcare providers worldwide. Recently, he participated in development of draft guidelines for the proper use of urine testing in addiction medicine, a collaborative project by the National Association of Addiction Treatment Providers (NAATP) with support from the Center for Lawful Access and Abuse Deterrence (CLAAD) and the American Society of Addiction Medicine (ASAM).

Dr. Fudin was named a 2010 “Parata/Pharmacy Times “Next generation Pharmacist Lifetime Achievement Honoree”.  He received the 2014 American Academy of Pain Medicine’s (AAPM) Presidential Commendation, in recognition as “a voice for scientific integrity and an advocate for people in pain.

Dr. Fudin is a reviewer for publications and poster submissions for both ACCP, ASHP, the American Academy of Pain Medicine, and other recognized professional pharmacy, medical, and nursing organizations. He is founder and two-time past Chair of the ACCP Pain Pharmacy Practice Network group.

Dr. Fudin practices as a Clinical Pharmacy Specialist and Director, PGY-2 Pharmacy Pain Residency Programs at the Stratton Veterans Administration Medical Center in Albany NY.  He is an Adjunct Associate Professor of Pharmacy Practice at Western New England University College of Pharmacy; Adjunct Assistant Professor of Pharmacy Practice at UCONN (University of Connecticut School of Pharmacy), and has several other academic affiliations including and the University at Buffalo School of Pharmacy and Pharmaceutical Sciences. He has been an Instructor of Pharmacology at SAGE Graduate School of Nursing for several years.  He is a Clinical Pharmacy Consultant to Homedical Associates, an innovative home-based academic patient care service dedicated to medically complex patients in their homes.

Dr. Fudin has been an invited speaker on pain management nationally and internationally at VA Hospitals and within the private sector and at major academic medical centers throughout the United States. In the last year alone, Dr. Fudin has lectured live and by Webinar on various pain-related topics to thousands of physicians, pharmacists, and other healthcare providers and administrators in over 30 states nationwide. He has presented symposia at local and regional forums (NYS Counsel of Health-system Pharmacists, Pharmaceutical Society of the State of NY), national meetings for the American College of Clinical Pharmacy, the American Pharmaceutical Association, PainWeek, American Academy of Pain Management, American Academy of Pain Medicine, American Academy of Pain Management, American Pain Society, and several other national meetings for physician, nurse, and osteopathic medicine groups. He is an active lecturer, writer, and researcher on pain management issues. Most recently, he began afreelance blog with Pharmacy Times with a unique perspective for pharmacist colleagues.

Recent national attention to the Risk Evaluation and Mitigation Strategies (REMS) has been an increasing subject of interest. Dr. Fudin has been called upon by several professional organizations to help strategize in anticipation of much needed education on proper opioid prescribing and monitoring.